Immunomodulatory effect of Eriobotrya japonica seed extract on allergic dermatitis rats

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 2, 2010, Pages 145-149

  Sun, Guangchen ^a   Liu, Yingqin ^a   Zhu, Jinling ^a   Iguchi, Miki ^c   Yoshioka, Saburo ^b   Miyamura, Mitsuhiko ^b   Kyotani, Shojiro ^c  

^a JIAMUSI UNIVERSITY   (China)

^b KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Allergic dermatitis; Cytokines; DNFB; Eosinophil; Eriobotrya japonica seed extract

Indexed keywords

ANTIALLERGIC AGENT; ERIOBOTRYA JAPONICA SEED EXTRACT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LOQUAT; MALE; NONHUMAN; RAT; SENSITIZATION; SKIN ALLERGY;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; EAR; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERIOBOTRYA; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

ERIOBOTRYA JAPONICA; RATTUS;

EID: 77954299450     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.145     Document Type: Article

References (21)

1. Gray DO, Fowden L. 1972. Isolation of 4-methyleneproline from Eriobotrya japonica. Phytochemistry 11: 745-750.
2. Yokota J, Takuma D, Hamada A, Onogawa M, Yoshioka S, Kusunose M, Miyamura M, Kyotani S, Nishioka Y. 2006. Scavenging of reactive oxygen species by Eriobotrya japonica seed extract. Biol Pharm Bull 29: 467-471.
3. Nishioka Y, Yoshioka S, Kusunose M, Cui T, Hamada A, Ono M, Miyamura M, Kyotani S. 2002. Effects of extract derived from Eriobotrya japonica on liver function improvement in rats. Biol Pharm Bull 25: 1053-1057.
4. Hamada A, Yoshioka S, Takuma D, Yokota J, Cui T, Kusunose M, Miyamura M, Kyotani S, Nishioka Y. 2004. The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats. BiolPharm Bull 27: 1961-1964.
5. Tanaka K, Nishizono S, Makino N, Tamaru S, Terai O, Ikeda I. 2008. Hypoglycemic activity of Eriobotrya japonica seeds in type 2 diabetic rats and mice. Biosci Biotechnol Biochem 72: 686-693.
6. Takuma D, Sun G, Yokota J, Hamada A, Onogawa M, Yoshioka S, Kusunose M, Miyamura M, Kyotani S, Nishioka Y. 2008. Effect of Eriobotrya japonica seed extract on 5-fluorouracil-induced mucositis in hamsters. Biol Pharm Bull 31: 250-254.
7. Sun G, Zhang Y, Takuma D, Onogawa M, Yokota J, Hamada A, Yoshioka S, Kusunose M, Miyamura M, Kyotani S, Nishioka Y. 2007. Effect of orally administered Eriobotrya japonica seed extract on allergic contact dermatitis in rats. J Pharm Pharmacol 59: 1405-1412.
8. Onogawa M, Sun G, Takuma D, Hamada A, Yokota J, Yoshioka S, Kusunose M, Miyamura M, Kyotani S, Nishioka Y. 2009. Animal studies supporting the inhibition of mast cell activation by Eriobotrya japonica seed extract. J Pharm Pharmacol 61: 237-241.
9. Frew JA. 1988. The relationship between infiltrating CD4 lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 141: 4158-4164.
10. Tahara E, Satoh T, Watanabe C, Shimada Y, Itoh T, Nagai H, Terasawa K, Saiki I. 1999. A third-phase cutaneous (very late phase) response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice. Allergol Int 48: 265-273.
11. Abramovitis W. 2005. Atopic dermatitis. J Am Acad Dermatol 53: s86-93.
12. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182: 99-108.
13. Kondo S, Pastore S, Shivji GM, McKenzie RC, Sauder DN. 1994. Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 13: 367-375.
14. Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103: 211-216.
15. Ferguson TA, Dube P, Griffith TS. 1994. Regulation of contact hypersensitivity by interleukin 10. J Exp Med 179: 1597-1604.
16. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. 1989. Reciprocal expression of interferon or IL-4 during the resolution or progression of murine leishmaniasis: evidence for distinct helper T cell subsets. J Exp Med 169: 59-72.
17. Romagnani S. 1991. Human Th1 and Th2 subsets: doubt no more. Immunol Today 12: 256-257.
18. Mosmann TR, Coffman RL. 1987. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
19. Gajewski TF, Schell SR, Nau G, Fitch FW. 1989. Regulation of T cell activation: differences among T-cell subsets. Immunol Rev 111: 79-110.
20. Stout RD, Bottomly K. 1989. Antigen-specific activation of effector macrophages by IFN-gamma producing (Th1) T cell clones. Failure of IL-4-producing (Th2) T cell clones to activate effector function in macrophages. J Immunol 142: 760-765.
21. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. 2001. Tissue eosinophilia in acute and chronic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 145: 720-729.